Literature DB >> 19616481

Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog.

Barbara M Schneider1, Nicholas H Dodman, Dominik Faissler, Niwako Ogata.   

Abstract

A Bernese mountain dog was diagnosed with complex partial seizures that were supported by electroencephalographic findings. Clinical signs of the problem included "star gazing," fly snapping, licking, vacuous chewing, and ongoing anxiety. Treatment with Huperzine A, a compound isolated from Chinese club moss with NMDA receptor blocking activity, anticholinesterase activity, and anticonvulsant properties, produced useful suppression of the abnormal behavior for more than months. A relapse occurred when the dog was treated with tramadol for joint pain and the improvement that had been made was not recaptured with Huperzine A. At this stage, phenobarbital therapy was instituted and the dog improved greatly. The role of Huperzine A in controlling seizures is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616481     DOI: 10.1016/j.yebeh.2009.06.011

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  Star gazing in a dog: atypical manifestation of upper gastrointestinal disease.

Authors:  Marie-Pier Poirier-Guay; Marie-Claude Bélanger; Diane Frank
Journal:  Can Vet J       Date:  2014-11       Impact factor: 1.008

Review 2.  A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.

Authors:  Mayuri Shukla; Prapimpun Wongchitrat; Piyarat Govitrapong
Journal:  Neurochem Res       Date:  2022-02-05       Impact factor: 3.996

3.  Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.

Authors:  Jennifer C Wong; Stacey B B Dutton; Stephen D Collins; Steven Schachter; Andrew Escayg
Journal:  Front Pharmacol       Date:  2016-10-17       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.